Pregnancies complicated by XXXX ( @entity2142 , elevated liver enzymes, and low platelets): subsequent pregnancy outcome and long-term prognosis.

@entity1 @entity3152 @entity101 @entity2102 @entity1468 @entity2142 @entity204
OBJECTIVE: Our purpose was to describe subsequent pregnancy outcome and long-term maternal prognosis in @entity1 with @entity2102 ( @entity2142 , elevated liver enzymes, and low platelets) during the index pregnancy. STUDY DESIGN: This is a descriptive and analytic study of @entity1 with @entity2102 admitted to E.H. Crump @entity1 's Hospital between August 1977 and July 1992. @entity2102 was defined by previously published laboratory criteria. Only @entity1 who were delivered > 2 years ago were included (median 4 years, range 2 to 14 years). Data on these @entity1 were obtained from our obstetric clinics, local physicians, local health departments, and hospital records. RESULTS: Adequate follow-up data were available on 341 @entity1 . One hundred fifty-two @entity1 subsequently became pregnant. One hundred thirty-nine normotensive @entity1 had 192 subsequent pregnancies. Complications included @entity1468 (19%), @entity3152 (21%), intrauterine growth restriction (12%), abruptio placentae (2%), perinatal @entity204 (4%), and @entity2102 (3%). Seven of the 113 @entity1 with at least 5 years' follow-up (6.2%) had chronic @entity101 , and 98 received oral contraceptive pills without complications. Thirteen @entity1 with preexisting chronic @entity101 had 20 subsequent pregnancies. These @entity1 had a higher rate of @entity1468 (75%), @entity3152 (80%), intrauterine growth restriction (45%), abruptio placentae (20%), and perinatal @entity204 (40%) but a low rate of recurrent @entity2102 (5%). CONCLUSIONS: @entity1 with @entity2102 have an increased risk of obstetric complications in future pregnancies but a low risk for recurrent @entity2102 . Oral contraceptive pills should not be contraindicated in normotensive @entity1 .
